Navigation Links
Omeros Corporation Reports Third Quarter 2013 Financial Results
Date:11/7/2013

FDA for the treatment of Huntington's disease.
  • Reported positive clinical data from its Phase 1 clinical trial of OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), an important regulator of the lectin pathway of the immune system. A Phase 2 clinical program to evaluate OMS721 in the treatment of thrombotic microangiopathies (TMAs), a family of disorders that occurs in the microcirculation of the body's organs, most commonly the kidney and brain, is expected to begin enrollment in early 2014.
  • Announced that its proprietary Cellular Redistribution Assay technology had "unlocked" six additional Class A orphan G protein-coupled receptors (GPCRs) for drug development, bringing the total number of Class A orphan GPCRs "unlocked" by Omeros to 52. These six orphan GPCRs are linked to a series of important indications, including cardiovascular indications, certain types of cancer and Grave's disease. Omeros also announced that it had identified small molecules that interact with two non-orphan Class B GPCRs, the glucagon-like peptide 1 receptor (GLP-1R) and the parathyroid hormone 1 receptor (PTH-1R). Both of these receptors are established drug targets – GLP-1R for diabetes and PTH-1R for osteoporosis.
  • Financial ResultsTotal operating expenses for the quarter ended September 30, 2013 were $13.6 million and included non-cash expenses of $3.2 million related to rent expense and stock-based compensation. For the same period in 2012, total operating expenses were $14.5 million, which included non-cash rent and stock-based compensation expenses of $576,000.

    The decrease in total operating expenses for the quarter ended September 30, 2013 compared to the prior year quarter is primarily due to a litigation settlement expense of $3.95 million recorded in the same period in 2012, which was reimbursed by CCIC in the fourth quarter of 2012. For the quarter ended Septemb
    '/>"/>

    SOURCE Omeros Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Omeros Announces Closing of $16.2 Million Registered Direct Offering of Common Stock
    2. Omeros to Present at the 12th Annual Needham Healthcare Conference
    3. Omeros Corporation Reports Fourth Quarter and Year-End 2012 Financial Results
    4. Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
    5. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
    6. Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRs
    7. Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs
    8. Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
    9. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2014 Financial Results
    10. Attention Amarin Corporation plc Investors: Amarin Corporation plc Misled Investors According to a Newly Filed Class Action
    11. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/31/2014)... 31, 2014 Huge event with ... future pharma industry health, analysis and forecasting   ... the closing of its most successful show to date ... 2,500 exhibitors. Held this year in Paris ... key players from 140+ countries representing every step of ...
    (Date:10/31/2014)... The evening of October 29th, ... in successful medical device development to give its ... takes to successfully innovate in the complex and ... two-hour on-site class, Insight gave master’s program students ... School of Engineering, medical and law schools an ...
    (Date:10/31/2014)... 31, 2014 Following the successful launch ... learning webinar to introduce its new product and demonstrate ... biostatisticians. , Launched in September, Formedix On Demand Services ... clinical trial automation tools. For the first time, these ... And by introducing Formations – a revolutionary new token-based ...
    (Date:10/31/2014)... Brady (NYSE:BRC), a global ... a new video testimonial on the effectiveness ... a research technician at the BloodCenter of Wisconsin discusses ... and storing hundreds of thousands of samples, and how ... , “At Brady, we design our label materials with ...
    Breaking Biology Technology:CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 2CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 3CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 4CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 5CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 6Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Brady Debuts New Lab Label Testimonial Video 2
    ... Oct. 7 Castle Access, Inc. announces the ... appointment aligns the Castle Access organization with that ... IT services provider, and gives clients in Southwestern ... of enterprise data center and mission-critical managed services. ...
    ... is developing and commercializing breakthrough single-molecule genomic analysis ... Officer, Han Cao, Ph.D., was awarded the Chinese ... Economic and Technical Cooperation Forum in Beijing, China ... recognition of Dr. Cao,s entrepreneurial spirit and success ...
    ... 7 GeneGo, Inc., a leading provider of databases, ... today that they have integrated GenomeQuest,s Sequence Data Management ... Using GenomeQuest,s interactive analysis, scientists who have drilled down ... of millions of reads, to thousands of expressed genes, ...
    Cached Biology Technology:Castle Access Names New Managing Director 2Castle Access Names New Managing Director 3BioNanomatrix Founder and CSO Dr. Han Cao Awarded Chinese Rising Star Entrepreneur Award 2GeneGo Announces Integration With GenomeQuest for Pathway Analysis of Next Generation Sequencing Data 2
    (Date:10/31/2014)... 31, 2014 – Dr. John Schoggins , Assistant ... received a prestigious New Innovator Award from the National ... understand why bats can harbor numerous viruses without becoming ... over five years is one of 85 awards given ... NIH Common Fund. The New Innovator Awards were created ...
    (Date:10/31/2014)... have been studying the behavior of approximately 300 ... years. They observed that ravens slowly build alliances ... However, they also observed that these affiliative interactions ... in about 50 % of the cases these ... affiliating ravens, intervening can be potentially risky when ...
    (Date:10/30/2014)... is available in German . ... prompt our fellow humans to behave socially? This is ... in game theory. Previous studies assumed that it is ... scientists from the Max Planck Institute for Evolutionary Biology ... an influence on the cooperative behaviour of others. However, ...
    Breaking Biology News(10 mins):UT Southwestern Microbiologist awarded prestigious NIH research grant 2Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4
    ... researchers at the University of Rochester Medical Center have discovered ... to harm the function of T-cells, which regulate the body's ... discovery adds insight to the latest trend in lead research, ... threat to understanding the long-term burden on the body, said ...
    ... successfully converted human embryonic stem cells into cartilage cells, ... grown for transplantation. , Cartilage is the dense connective ... movement of joints. , Research to be published ... embryonic stem cells to become cartilage cells. This could ...
    ... amateur fossil finder Van Turner discovered a small vertebra at ... the creature was unlike anything in the fossil record. Scientists ... of an extinct line of lizards with an evolutionary twist: ... the remains to paleontologists at the Dallas Museum of Natural ...
    Cached Biology News:The dangerous legacy of lead 2Scientists use stem cells to grow cartilage 2Missing fossil link 'Dallasaurus' found 2Missing fossil link 'Dallasaurus' found 3Missing fossil link 'Dallasaurus' found 4
    ... C-terminal reactive. Cross-reacts fully with GLP-1(1-36) ... with the unamidated forms GLP-1(7-37) and ... as hGLP-2, glucagon, hGIP and VIP.,SPECIES ... identical in all mammalian species studied ...
    Anti Human JAM-1, Monoclonal Antibody, Clone M.Ab.F11...
    MOUSE ANTI HUMAN CYTOKERATIN 1-8...
    Immunogen: Tissue / cell preparation. (Murine EHS laminin preparation) Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Biology Products: